{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:36:22Z","timestamp":1790516182063,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.pupt.2011.12.012","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T11:17:27Z","timestamp":1325848647000},"page":"115-118","source":"Crossref","is-referenced-by-count":58,"title":["PGE2 receptor (EP4) agonists: Potent dilators of human bronchi and future asthma therapy?"],"prefix":"10.1016","volume":"25","author":[{"given":"C.","family":"Benyahia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kanyinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Boukais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Danel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Les\u00e9che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Longrois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Norel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2011.12.012_bib1","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2011.02.020","article-title":"Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists","volume":"57","author":"Hawkins","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.pupt.2011.12.012_bib2","doi-asserted-by":"crossref","first-page":"L469","DOI":"10.1152\/ajplung.2001.281.2.L469","article-title":"EP2 receptors mediate airway relaxation to substance P, ATP, and PGE2","volume":"281","author":"Fortner","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pupt.2011.12.012_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1476-5381.1986.tb10155.x","article-title":"Characterization of prostanoid relaxant\/inhibitory receptors (psi) using a highly selective agonist, TR4979","volume":"87","author":"Gardiner","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.012_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1476-5381.1994.tb13042.x","article-title":"Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea","volume":"112","author":"Lydford","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.012_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1388-1981(99)00164-X","article-title":"The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs","volume":"1483","author":"Abramovitz","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pupt.2011.12.012_bib6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjp.0702392","article-title":"Prostanoid receptors involved in the relaxation of human bronchial preparations","volume":"126","author":"Norel","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.012_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1527-3466.1993.tb00274.x","article-title":"AH13205, a selective prostanoid EP2-receptor agonist","volume":"11","author":"Nials","year":"1993","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.pupt.2011.12.012_bib8","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/en.141.4.1554","article-title":"The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs","volume":"141","author":"Suzawa","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.pupt.2011.12.012_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.bjp.0706726","article-title":"GW627368X (N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl] acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist","volume":"148","author":"Wilson","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.012_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1476-5381.1991.tb12474.x","article-title":"Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations","volume":"104","author":"Norel","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.012_bib11","first-page":"1001","article-title":"Selective agonists and antagonists for prostaglandin E2 receptor subtypes","volume":"45","author":"Maruyama","year":"2000","journal-title":"Tanpakushitsu Kakusan Koso"},{"key":"10.1016\/j.pupt.2011.12.012_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3987\/COM-04-S(P)47","article-title":"Discovery and synthesis of a potent, selective and orally bioavailable EP4 receptor agonist","volume":"64","author":"Young","year":"2004","journal-title":"Heterocycles"},{"key":"10.1016\/j.pupt.2011.12.012_bib13","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/bjp.2008.214","article-title":"Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype","volume":"154","author":"Foudi","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.012_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/thx.2010.158568","article-title":"EP4 receptor as a new target for bronchodilator therapy","author":"Buckley","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2011.12.012_bib15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1476-5381.1995.tb13294.x","article-title":"Effects of beta 2-adrenoceptor agonists on anti-IgE-induced contraction and smooth muscle reactivity in human airways","volume":"114","author":"Gorenne","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.012_bib16","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1476-5381.1995.tb16393.x","article-title":"Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery","volume":"116","author":"Baxter","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.012_bib17","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.bjp.0705645","article-title":"EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries","volume":"141","author":"Davis","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.012_bib18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1476-5381.2011.01264.x","article-title":"Differential reactivity of human mammary artery and saphenous vein to prostaglandin E(2): implication for cardiovascular grafts","volume":"163","author":"Foudi","year":"2011","journal-title":"Br J Pharmacol"}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553912000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553912000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T04:51:13Z","timestamp":1561179073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553912000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1094553912000053"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2011.12.012","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}